Pharmacist's Role in Managing and Preventing Newborn and Infants Sepsis: A Prospective Observational Review

Background: Worldwide, neonatal and infant sepsis continues to be a major cause of morbidity and mortality, contributing to 15% of all neonatal fatalities. Using efficient management techniques is essential to enhancing results and lowering antibiotic resistance. Additionally, the absence of diseases, infection cases may occasionally have negative consequences. For this reason, the physician cannot make a decision. Many factors, such as the baby's clinical health, hospital hygiene, and other factors, are to blame for this. It is necessary to find a quick and accurate diagnostic process to prevent inconsistent results. Approximately 30 to 50% of baby deaths in developing nations are caused by sepsis. Early detection, rigorous treatment, and anti-microbial medications can all help reduce and prevent this sepsis fatality rate. Each time we interact with a baby, we must wash our hands to avoid nosocomial infections.Pharmacist-led initiatives have demonstrated potential for improving patient care and optimizing antimicrobial therapy. Objective: To investigate the impact of pharmacist-led interventions on neonatal and infant sepsis management, focusing on incidence density, pathogen identification, antibiotic misuse, hospital stay, and mortality rates.